CorVel (NASDAQ:CRVL) Stock Price Down 5.7% – What’s Next?

CorVel Corp. (NASDAQ:CRVL) fell 5.7% during mid-day trading on Thursday . The company traded as low as $61.75 and last traded at $60.62. 8,610 shares were traded during mid-day trading, a decline of 96% from the average session volume of 229,025 shares. The stock had previously closed at $64.26.

CorVel News Summary

Here are the key news stories impacting CorVel this week:

• Positive Sentiment: CorVel reported fiscal 2026 revenue of $959 million, up 7% year over year, while EPS rose 17% to $2.14, showing continued top-line growth and improving profitability. CorVel Announces Revenues and Earnings
• Positive Sentiment: Q4 revenue increased to $248.6 million and EPS climbed 20% to $0.61, supported by stronger gross profit and margin expansion. CorVel Announces Revenues and Earnings
• Positive Sentiment: Management highlighted strong demand for CERIS, its healthcare payment accuracy platform, plus continued investment in AI, automation, and connectivity, which may support future growth and revenue visibility. CorVel Earnings Call Highlights CERIS-Driven Growth
• Neutral Sentiment: CorVel ended the quarter with $233 million in cash and no borrowings, and it repurchased $20.1 million of stock, underscoring a strong balance sheet and shareholder returns. CorVel Announces Revenues and Earnings
• Negative Sentiment: Recent insider-trading data shows only sales and no purchases over the past six months, which can sometimes weigh on sentiment.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered shares of CorVel from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, April 6th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

CorVel Price Performance

The business has a fifty day moving average of $55.50 and a 200 day moving average of $61.82. The stock has a market cap of $3.17 billion, a price-to-earnings ratio of 30.35 and a beta of 0.98.

CorVel (NASDAQ:CRVL) last released its quarterly earnings data on Tuesday, May 19th. The business services provider reported $0.61 EPS for the quarter. CorVel had a return on equity of 30.15% and a net margin of 11.23%.The firm had revenue of $248.55 million for the quarter.

Insider Buying and Selling

In related news, insider Maxim Shishin sold 2,400 shares of the stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $54.00, for a total value of $129,600.00. Following the transaction, the insider owned 7,050 shares in the company, valued at approximately $380,700. This represents a 25.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 44.56% of the company’s stock.

Hedge Funds Weigh In On CorVel

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CRVL. Norges Bank acquired a new position in CorVel during the fourth quarter valued at approximately $29,250,000. Qube Research & Technologies Ltd boosted its position in shares of CorVel by 100.9% in the third quarter. Qube Research & Technologies Ltd now owns 236,713 shares of the business services provider’s stock valued at $18,326,000 after acquiring an additional 118,879 shares during the period. Algert Global LLC boosted its position in shares of CorVel by 73.4% in the third quarter. Algert Global LLC now owns 217,559 shares of the business services provider’s stock valued at $16,843,000 after acquiring an additional 92,077 shares during the period. Cubist Systematic Strategies LLC boosted its position in shares of CorVel by 249.0% in the second quarter. Cubist Systematic Strategies LLC now owns 117,395 shares of the business services provider’s stock valued at $12,066,000 after acquiring an additional 83,757 shares during the period. Finally, Quantinno Capital Management LP boosted its position in shares of CorVel by 328.4% in the first quarter. Quantinno Capital Management LP now owns 81,544 shares of the business services provider’s stock valued at $4,456,000 after acquiring an additional 62,508 shares during the period. Institutional investors and hedge funds own 51.36% of the company’s stock.

About CorVel

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).